BostonGene and Exigent Genomic INsight Study of Molecular Testing to Guide Treatment in Advanced Breast, Lung, Melanoma, and Sarcoma Cancers in Community Settings

What this Trial Is About

Researchers are evaluating the effectiveness of comprehensive molecular testing for patients with advanced cancers in community settings. The study focuses on breast cancer, non-small cell lung cancer, melanoma, and sarcoma. It aims to identify actionable genetic findings, assess feasibility and turnaround time of testing, and determine how often patients enroll in clinical trials based on the test results. The study uses the BostonGene Tumor Portrait test, a high-throughput sequencing platform that provides detailed genetic and molecular information about tumors and their environments. The research includes four groups of 100 patients each, categorized by cancer type. The study lasts up to two years, collecting data on demographics, medical history, treatment decisions, and patient outcomes. Participants will undergo genomic and molecular profiling with data gathered on test results, treatment plans, and patient progress. Researchers will measure how frequently actionable findings occur and the speed of test results. They will also observe how often patients receive therapies matched to their molecular profiles and track treatment decisions over time.

BostonGene and Exigent Genomic INsight Study